drugset / Trial / NCT06600425
A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults With PCD
NaSingle-groupOpen-labelTreatment
Summary
This is the second in-human study with RCT1100 and is designed to provide safety, tolerability and preliminary efficacy data for future clinical studies.
Timeline
- Start
- 2024-09-20
- Primary completion
- 2025-06-06
- Completion
- 2025-08-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RCT1100 | Messenger RNA (mRNA) | — | Inhaled |